Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Brazil

Country May Soon Be Self-Reliant In Efavirenz Production

October 2008 | Industry News

News: According to the Brazilian health minister, Brazil will soon be self-reliant in the production of efavirenz, a drug used in the treatment of HIV/AIDS. The statement comes after Farmanguinhos, the state-owned pharmaceutical laboratory, announced positive bioavailability trial results for its generic version of Merck & Co's Stocrin (efavirenz).

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>